Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial von de Bono, Johann Sebastian, Dr, Oudard, Stephane, MD, Ozguroglu, Mustafa, MD, Hansen, Steinbjørn, MD, Machiels, Jean-Pascal, MD, Kocak, Ivo, MD, Gravis, Gwenaëlle, MD, Bodrogi, Istvan, MD, Mackenzie, Mary J, MD, Shen, Liji, PhD, Roessner, Martin, MS, Gupta, Sunil, MD, Sartor, A Oliver, MD

Volltext

Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy von McKay, Rana R, Kroeger, Nils, Xie, Wanling, Lee, Jae-Lyun, Knox, Jennifer J, Bjarnason, Georg A, MacKenzie, Mary J, Wood, Lori, Srinivas, Sandy, Vaishampayan, Ulka N, Rha, Sun-Young, Pal, Sumanta K, Donskov, Frede, Tantravahi, Srinivas K, Rini, Brian I, Heng, Daniel Y.C, Choueiri, Toni K

Volltext

The Conundrum of Low COVID-19 Mortality Burden in sub-Saharan Africa: Myth or Reality? von Adams, Janica, MacKenzie, Mary J., Amegah, Adeladza Kofi, Ezeh, Alex, Gadanya, Muktar A., Omigbodun, Akinyinka, Sarki, Ahmed M., Thistle, Paul, Ziraba, Abdhalah K., Stranges, Saverio, Silverman, Michael

Volltext

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study von Heng, Daniel YC, Dr, Xie, Wanling, MS, Regan, Meredith M, ScD, Harshman, Lauren C, MD, Bjarnason, Georg A, MD, Vaishampayan, Ulka N, MD, Mackenzie, Mary, MD, Wood, Lori, MD, Donskov, Frede, MD, Tan, Min-Han, MD, Rha, Sun-Young, MD, Agarwal, Neeraj, MD, Kollmannsberger, Christian, MD, Rini, Brian I, Prof, Choueiri, Toni K, MD

Volltext

Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consort... von Kroeger, Nils, Xie, Wanling, Lee, Jae‐Lyn, Bjarnason, Georg A., Knox, Jennifer J., MacKenzie, Mary J., Wood, Lori, Srinivas, Sandy, Vaishamayan, Ulka N., Rha, Sun‐Young, Pal, Sumanta K., Yuasa, Takeshi, Donskov, Frede, Agarwal, Neeraj, Kollmannsberger, Christian K., Tan, Min‐Han, North, Scott A., Rini, Brian I., Choueiri, Toni K., Heng, Daniel Y.C.

Volltext

CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II colon cancer von Cecchini, Matthew J., Walsh, Joanna C., Parfitt, Jeremy, Chakrabarti, Subrata, Correa, Rohann J., MacKenzie, Mary J., Driman, David K.

Volltext

The Impact of Low Serum Sodium on Treatment Outcome of Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Cancer Database Con... von Schutz, Fabio A.B, Xie, Wanling, Donskov, Frede, Sircar, Monica, McDermott, David F, Rini, Brian I, Agarwal, Neeraj, Pal, Sumanta Kumar, Srinivas, Sandy, Kollmannsberger, Christian, North, Scott A, Wood, Lori A, Vaishampayan, Ulka, Tan, Min-Han, Mackenzie, Mary J, Lee, Jae Lyun, Rha, Sun-Young, Yuasa, Takeshi, Heng, Daniel Y.C, Choueiri, Toni K

Volltext

Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer von TANG, Patricia A, COHEN, Steven J, KOLLMANNSBERGER, Christian, BJARNASON, Georg, VIRIK, Kiran, MACKENZIE, Mary J, LOURENCO, Lillian, WANG, Lisa, CHEN, Alice, MOORE, Malcolm J

Volltext

Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy von Kroeger, Nils, Choueiri, Toni K, Lee, Jae-Lyn, Bjarnason, Georg A, Knox, Jennifer J, MacKenzie, Mary J, Wood, Lori, Srinivas, Sandy, Vaishamayan, Ulka N, Rha, Sun-Young, Pal, Sumanta K, Yuasa, Takeshi, Donskov, Frede, Agarwal, Neeraj, Tan, Min-Han, Bamias, Aristotelis, Kollmannsberger, Christian K, North, Scott A, Rini, Brian I, Heng, Daniel Y.C

Volltext

A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic rena... von Correa, Rohann J M, Ahmad, Belal, Warner, Andrew, Johnson, Craig, MacKenzie, Mary J, Pautler, Stephen E, Bauman, Glenn S, Rodrigues, George B, Louie, Alexander V

Volltext

A phase I study of temsirolimus and metformin in advanced solid tumours von MacKenzie, Mary J., Ernst, Scott, Johnson, Craig, Winquist, Eric

Volltext

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study von Harshman, Lauren C, MD, Xie, Wanling, MS, Bjarnason, Georg A, MD, Knox, Jennifer J, MD, MacKenzie, Mary, MD, Wood, Lori, MD, Srinivas, Sandy, MD, Vaishampayan, Ulka N, MD, Tan, Min-Han, MD, Rha, Sun-Young, Prof, Donskov, Frede, MD, Agarwal, Neeraj, MD, Kollmannsberger, Christian, MD, North, Scott, MD, Rini, Brian I, Prof, Heng, Daniel YC, MD, Choueiri, Toni K, Dr

Volltext

Molecular therapy in pancreatic adenocarcinoma von MacKenzie, Mary J

Volltext

Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study von HOTTE, Sébastien J, WINQUIST, Eric W, LAMONT, Elizabeth, MACKENZIE, Mary, VOKES, Everett, CHEN, Eric X, BROWN, Shirley, POND, Gregory R, MURGO, Anthony, SIU, Lillian L

Volltext

Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer von Vincent, Mark D, Breadner, Daniel, Soulieres, Denis, Kerr, Ian G, Sanatani, Michael, Kocha, Walter, Klimo, Peter, MacKenzie, Mary J, O'Connell, Anne, Whiston, Frances, Malpage, Anne S, Stitt, Larry, Welch, Stephen A

Volltext

Chemotherapy-Associated Osteonecrosis in Cancer Patients with Solid Tumours: A Systematic Review von Shim, Katharine, MacKenzie, Mary J., Winquist, Eric

Volltext

Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancer von Hecht, J Randolph, Reid, Tony R, Garrett, Christopher R, Beck, J Thaddeus, Davidson, Sheldon J, Mackenzie, Mary J, Brandt, Ulrike, Rizvi, Syed, Sharma, Sunil

Volltext

Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population von Khambati, Husain K, Choueiri, Toni K, Kollmannsberger, Christian K, North, Scott, Bjarnason, George A, Vaishampayan, Ulka N, Wood, Lori, Knox, Jennifer J, Tan, Min-Han, MacKenzie, Mary J, Donskov, Frede, Rini, Brian I, Heng, Daniel Y.C

Volltext

A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consorti... von Sridhar, Srikala S., Mackenzie, Mary J., Hotte, Sebastien J., Mukherjee, Som D., Tannock, Ian F., Murray, Nevin, Kollmannsberger, Christian, Haider, Masoom A., Chen, Eric X., Halford, Robert, Wang, Lisa, Ivy, S. Percy, Moore, Malcolm J.

Volltext

A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer von MACKAY, Helen, HEDLEY, David, WRIGHT, John, SIU, Lillian, MOORE, Malcolm, OZA, Amit, MAJOR, Pierre, TOWNSLEY, Carol, MACKENZIE, Mary, VINCENT, Mark, DEGENDORFER, Pam, TSAO, Ming-Sound, NICKLEE, Trudey, BIRLE, Diana

Volltext